Arad Ltd

Arad Ltd maintains a capital structure with a debt-to-equity ratio of 0.51, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.89, suggesting it can cover its short-term obligations with its current assets. However, the firm's cash and equivalents of $18.83 million are significantly lower than its long-term debt of $96.86 million, resulting in a net cash position that is negative after subtracting total debt.

In terms of profitability, Arad's return on equity (ROE) of 15.28% and return on assets (ROA) of 7.25% outperform the typical benchmarks for the industrial machinery sector. These metrics suggest that the company is effectively utilizing its equity and assets to generate returns. The operating margin, calculated as operating income of $38.01 million on revenue of $420.76 million, stands at 9.03%, which is a strong indicator of cost control and operational efficiency.

Arad's revenue is primarily concentrated in its core industrial machinery and equipment segment, with no disclosed geographic diversification in the latest financial data. This concentration may expose the company to regional economic fluctuations and sector-specific risks. The absence of detailed geographic breakdowns in the financial snapshot limits the ability to assess exposure to different markets.

The company's growth trajectory is supported by a positive free cash flow of $21.34 million and an operating cash flow of $31.16 million, which provide flexibility for reinvestment and debt servicing. While the capital expenditure of $13.04 million indicates ongoing investment in infrastructure, the outlook for the current fiscal year does not specify projected revenue growth. The absence of a detailed growth forecast makes it challenging to assess the company's long-term expansion plans.

Arad's risk profile is marked by a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations without external financing. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving shareholder value.

Recent events and filings have not been disclosed in the available data, limiting the ability to assess any material developments that may impact the company's operations or financial health. The absence of recent transcripts or filings means that investors must rely on the latest financial snapshot for insights into Arad's strategic direction and performance.

Arad Ltd (ARD.TA) is currently undergoing its first formal analysis, meaning there is no prior historical basis for computing material changes or deltas in its financial profile. Consequently, no specific operational shifts, earnings surprises, or strategic pivots can be identified from recent data streams, as the system lacks a previous snapshot for comparison. The company’s current structural footprint is notably sparse, with zero recorded officers, analysts, index memberships, or top holders in the available dataset. This absence of traditional corporate governance and market participation metrics suggests that Arad Ltd may be a micro-cap entity, a newly listed firm, or one with limited public disclosure and institutional engagement. Market attention for Arad Ltd has been intermittent over the observed period. Dispatch activity was recorded on June 26, July 2, July 4, and July 16, 2026, with no activity on the intervening days. These isolated instances of coverage do not indicate a sustained news cycle or a specific catalyst driving consistent investor interest. Given the lack of analyst coverage, index inclusion, or significant holder data, the significance of Arad Ltd’s current status lies primarily in its baseline establishment. Investors and observers should note that the absence of data points is itself a material characteristic, highlighting the need for caution and further due diligence before drawing conclusions about the company’s financial health or market trajectory.